No Result
View All Result
  • Home
  • Stock Watchlist
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
healthtechmovers.com
No Result
View All Result

3 HealthTech Stocks up over 94% past 10 days (IMGN, INAB, ONTX stock)

by Staff Editor
May 04, 2023
in Health Health Technology Health Services Watchlist 

Today, our screeners were at work and below is a list of 3 HealthTech Stocks up over 94% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.

ImmunoGen, IMGN

Summary: ImmunoGen Inc is a development-stage biotechnology company focused on the development of targeted cancer therapeutics using its proprietary antibody-drug conjugate technology. ImmunoGen's ADC technology is used in three development-stage candidates in its own pipeline, Roche's marketed product, Kadcyla and in development programs of its partners Bayer, Biotest, CytomX, Novartis, Sanofi, Roche, Takeda, Debiopharm & Jazz Pharmaceuticals.'Among ImmunoGen's wholly owned candidates, mirvetuximab soravtansine, a first-in-class ADC targeting folate-receptor alpha, is being developed as a single-agent therapy for platinum-resistant ovarian cancer and in combination regimens for both platinum-resistant and platinum-sensitive disease.
Recent IMGN Stock Price (approx 10:00am EST.): $12.99
Previous Close for IMGN Stock: $12.26
Percentage Price Change Past 10 Days for IMGN stock:  

TipRanks.com reports that ImmunoGen stock currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating for IMGN stock with an average price target is $14.33. 

What is the forecast for IMGN stock? Here are 3rd party ratings for IMGN stock: 

  • TipRanks.com rating for IMGN stock: Strong Buy
  • TradingView.com for IMGN stock: : Strong Buy
  • Yahoo! Finance for IMGN stock: : Bearish
  • Barchart.com for IMGN stock: : buy
  • Zacks Rating for IMGN stock: : Top 46% (114 out of 249)
What’s the sentiment on the street for IMGN stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for IMGN stock: : Very Bullish
  • Blogger Consensus for IMGN stock: : Bullish
  • Media Buzz for IMGN stock: : Very High
  • Insider Signal for IMGN stock: : ―
  • Investor Sentiment for IMGN stock: : Very Positive
  • Hedge Fund signal for IMGN stock: : Neutral

Click for the IMGN stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

IN8bio, INAB

Summary: IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.
Recent INAB Stock Price (approx 10:00am EST.): $2.36
Previous Close for INAB Stock: $2.36
Percentage Price Change Past 10 Days for INAB stock:  

TipRanks.com reports that IN8bio stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for INAB stock with an average price target is $13.00. 

What is the forecast for INAB stock? Here are 3rd party ratings for INAB stock: 

  • TipRanks.com rating for INAB stock: Moderate Buy
  • TradingView.com for INAB stock: : Strong Buy
  • Yahoo! Finance for INAB stock: : Bullish
  • Barchart.com for INAB stock: : Weak buy
  • Zacks Rating for INAB stock: : Top 37% (93 out of 249)
What’s the sentiment on the street for INAB stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for INAB stock: : Very Bullish
  • Blogger Consensus for INAB stock: : ―
  • Media Buzz for INAB stock: : Very Low
  • Insider Signal for INAB stock: : ―
  • Investor Sentiment for INAB stock: : ―
  • Hedge Fund signal for INAB stock: : No Signal

Click for the INAB stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Onconova Therapeutics, ONTX

Summary: Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company's products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib. Onconova Therapeutics, Inc. is headquartered in Newtown, Pennsylvania.
Recent ONTX Stock Price (approx 10:00am EST.): $1.39
Previous Close for ONTX Stock: $1.39
Percentage Price Change Past 10 Days for ONTX stock:  

TipRanks.com reports that Onconova Therapeutics stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for ONTX stock with an average price target is $9.00. 

What is the forecast for ONTX stock? Here are 3rd party ratings for ONTX stock: 

  • TipRanks.com rating for ONTX stock: Moderate Buy
  • TradingView.com for ONTX stock: : Buy
  • Yahoo! Finance for ONTX stock: : Bullish
  • Barchart.com for ONTX stock: : buy
  • Zacks Rating for ONTX stock: : Top 46% (114 out of 249)
What’s the sentiment on the street for ONTX stock?
Current ratings compiled by TipRanks.com) 
  • News Sentiment for ONTX stock: : Very Bullish
  • Blogger Consensus for ONTX stock: : ―
  • Media Buzz for ONTX stock: : Low
  • Insider Signal for ONTX stock: : ―
  • Investor Sentiment for ONTX stock: : Very Positive
  • Hedge Fund signal for ONTX stock: : No Signal

Click for the ONTX stock Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------


Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.

Tags: healthtech stocks ONTX stock price Onconova Therapeutics stock price ONTX news Onconova Therapeutics news 

Related Posts

From Shrinkflation to Economic Collapse: Is a Financial Storm Brewing?

Oct 13, 2024

The Week Ahead: Earnings Season Kicks Off and Retail Sales in Focus

Oct 13, 2024
Dividend 

4 Stocks Up 30%+ in 5 Days: EV, Lithium, and Tech Leaders

Oct 09, 2024
UP Fintech Holding Limited stock TIGR TIGR price target Financial Services stock watchlist Financial Services stocks 

4 Soaring Stocks Up Over 46% in 5 Days

Oct 04, 2024
Dividend 

3 Dividend Stocks Up Over 30% in the Last Week

Oct 04, 2024

Massive "Backdoor" Pre-IPO Play in Musk's $100 Billion Starlink?

Oct 03, 2024
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Email Notice, Data Use and DMCA
  • Privacy Policy
  • Terms of Use and Disclaimer
  • 17B List of Disclosures
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This site contains articles and videos are offered for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation or be relied upon as personalized investment advice. We are a financial publisher. We are not financial advisors and cannot give personalized advice. There is a risk of loss in all trading, and you may lose some or all of your original investment. Results presented are not typical. Never make any investment or trade with our first consulting with your investment advisor and after doing your own due diligence. This webpage and website is protected by copyright laws of the United states and international treaties.

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In